Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023
- None.
- None.
AUSTIN, TX and DURHAM, NC, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced it will report its third-quarter 2023 financial results and provide a general business overview on Thursday, November 9, 2023.
Title: Shattuck Labs Third-Quarter 2023 Earnings Call
Speakers: Taylor Schreiber, CEO; Andrew Neill, CFO; Lini Pandite, CMO
Date & Time: Thursday, November 9, 2023 at 8:00 a.m. ET
Dial-in Details: Toll-Free Dial-In Number: 1 (888) 440-4368
Toll Dial-In Number: 1 (646) 960-0856
Conference ID: 5023003
Webcast Details: https://events.q4inc.com/attendee/625426190
To listen to the live webcast, please visit the Investor Relations page of the Shattuck Labs website here. Participants may register for the call here. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event.
A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About Shattuck Labs, Inc.
Shattuck Labs, Inc. (NASDAQ: STTK) is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Compounds derived from Shattuck’s proprietary Agonist Redirected Checkpoint, (“ARC®”), platform are designed to simultaneously inhibit checkpoint molecules and activate costimulatory molecules with a single therapeutic. The company’s lead SL-172154 (SIRPα-Fc-CD40L) program, which is designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway, is being evaluated in multiple Phase 1 trials. Shattuck has offices in both Austin, Texas and Durham, North Carolina. For more information, please visit: www.ShattuckLabs.com.
The Company intends to use the investor relations portion of its website as a means of disclosing material non-public information and for complying with disclosure obligations under Regulation FD.
Investor & Media Contact:
Conor Richardson
Vice President of Investor Relations
Shattuck Labs, Inc.
InvestorRelations@shattucklabs.com
FAQ
When will Shattuck Labs report its third-quarter 2023 financial results?
Who are the speakers for the earnings call?
What is the webcast link for the event?
How can I listen to the live webcast?
Will there be a replay of the webcast?
